Literature DB >> 22394059

Clinical presentation, immunohistochemistry and electron microscopy indicate neurofibromatosis type 2-associated gliomas to be spinal ependymomas.

Christian Hagel1, Anat O Stemmer-Rachamimov, Antje Bornemann, Martin Schuhmann, Christoph Nagel, Susan Huson, D Gareth Evans, Scott Plotkin, Cordula Matthies, Lan Kluwe, Victor-Felix Mautner.   

Abstract

Neurofibromatosis type 2 (NF2) is a hereditary tumor syndrome. The hallmark of NF2 is bilateral vestibular schwannoma. In addition, glioma is one of the diagnostic criteria of NF2. In this retrospective study the clinical presentation and histopathological features of 12 spinal gliomas from NF2 patients were assessed. Ten tumors were previously diagnosed as ependymomas and two as astrocytomas. However, upon re-evaluation both astrocytomas expressed epithelial membrane antigen in a dot-like fashion and in one case it was possible to perform electron microscopy revealing junctional complexes and cilia typical for ependymoma. The findings suggest that NF2-associated spinal gliomas are ependymomas. Based on the fact that NF2-associated gliomas are almost exclusively spinal and that no NF2 mutations have been found in sporadic cerebral gliomas, we suggest that "glioma" in the current diagnostic criteria for NF2 should be specified as "spinal ependymoma".
© 2012 Japanese Society of Neuropathology.

Entities:  

Mesh:

Year:  2012        PMID: 22394059     DOI: 10.1111/j.1440-1789.2012.01306.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  7 in total

1.  European genetic ancestry associated with risk of childhood ependymoma.

Authors:  Chenan Zhang; Quinn T Ostrom; Helen M Hansen; Julio Gonzalez-Maya; Donglei Hu; Elad Ziv; Libby Morimoto; Adam J de Smith; Ivo S Muskens; Cassie N Kline; Zalman Vaksman; Hakon Hakonarson; Sharon J Diskin; Carol Kruchko; Jill S Barnholtz-Sloan; Vijay Ramaswamy; Francis Ali-Osman; Melissa L Bondy; Michael D Taylor; Catherine Metayer; Joseph L Wiemels; Kyle M Walsh
Journal:  Neuro Oncol       Date:  2020-11-26       Impact factor: 12.300

2.  Spinal ependymomas in NF2: a surgical disease?

Authors:  M Kalamarides; W Essayed; J P Lejeune; R Aboukais; O Sterkers; D Bernardeschi; M Peyre; S K Lloyd; S Freeman; C Hammerbeck-Ward; M Kellett; S A Rutherford; D G Evans; O Pathmanaban; A T King
Journal:  J Neurooncol       Date:  2017-11-29       Impact factor: 4.130

Review 3.  Spinal cord tumours: advances in genetics and their implications for treatment.

Authors:  Patricia L Zadnik; Ziya L Gokaslan; Peter C Burger; Chetan Bettegowda
Journal:  Nat Rev Neurol       Date:  2013-03-26       Impact factor: 42.937

Review 4.  Advances in the treatment of neurofibromatosis-associated tumours.

Authors:  Andrew L Lin; David H Gutmann
Journal:  Nat Rev Clin Oncol       Date:  2013-08-13       Impact factor: 66.675

5.  Incidental parenchymal magnetic resonance imaging findings in the brains of patients with neurofibromatosis type 2.

Authors:  Wendy S Vargas; Linda A Heier; Fausto Rodriguez; Amanda Bergner; Kaleb Yohay
Journal:  Neuroimage Clin       Date:  2014-01-04       Impact factor: 4.881

Review 6.  An update on the CNS manifestations of neurofibromatosis type 2.

Authors:  Shannon Coy; Rumana Rashid; Anat Stemmer-Rachamimov; Sandro Santagata
Journal:  Acta Neuropathol       Date:  2019-06-04       Impact factor: 17.088

Review 7.  The Neurofibromatoses.

Authors:  Said Farschtschi; Victor-Felix Mautner; Anna Cecilia Lawson McLean; Alexander Schulz; Reinhard E Friedrich; Steffen K Rosahl
Journal:  Dtsch Arztebl Int       Date:  2020-05-15       Impact factor: 5.594

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.